$SPPI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SPECTRUM PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SPECTRUM PHARMACEUTICALS INC. Get notifications about new insider transactions in SPECTRUM PHARMACEUTICALS INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 05 2013 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Buy | M | 3.92 | 5,000 | 19,600 | 12,550 | 7.6 K to 12.6 K (+66.23 %) |
| Feb 06 2013 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Option Exercise | M | 3.92 | 1,700 | 6,664 | 28,300 | |
| Feb 06 2013 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Option Exercise | M | 4.26 | 3,300 | 14,058 | 0 | |
| Feb 06 2013 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Sell | S | 12.25 | 1,700 | 20,823 | 2,250 | 4 K to 2.3 K (-43.04 %) |
| Feb 06 2013 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Buy | M | 3.92 | 1,700 | 6,664 | 3,950 | 2.3 K to 4 K (+75.56 %) |
| Feb 06 2013 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Sell | S | 12.25 | 3,300 | 40,421 | 2,250 | 5.6 K to 2.3 K (-59.46 %) |
| Feb 06 2013 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Buy | M | 4.26 | 3,300 | 14,058 | 5,550 | 2.3 K to 5.6 K (+146.67 %) |
| Jan 07 2013 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Payment of Exercise | F | 11.66 | 23,344 | 272,191 | 1,460,762 | 1.5 M to 1.5 M (-1.57 %) |
| Jan 02 2013 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Sell | S | 11.24 | 205,836 | 2,313,267 | 1,484,106 | 1.7 M to 1.5 M (-12.18 %) |
| Jan 02 2013 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Sell | S | 11.35 | 172,507 | 1,957,954 | 1,689,942 | 1.9 M to 1.7 M (-9.26 %) |
| Jan 02 2013 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Option Exercise | M | 4.26 | 5,000 | 21,300 | 3,300 | |
| Jan 02 2013 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Sell | S | 11.42 | 5,000 | 57,109 | 2,250 | 7.3 K to 2.3 K (-68.97 %) |
| Jan 02 2013 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Buy | M | 4.26 | 5,000 | 21,300 | 7,250 | 2.3 K to 7.3 K (+222.22 %) |
| Dec 21 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Option Exercise | A | 11.34 | 20,000 | 226,800 | 20,000 | |
| Dec 21 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Payment of Exercise | F | 11.34 | 4,700 | 53,298 | 7,550 | 12.3 K to 7.6 K (-38.37 %) |
| Dec 21 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Grant | A | 11.34 | 10,000 | 113,400 | 12,250 | 2.3 K to 12.3 K (+444.44 %) |
| Dec 21 2012 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Option Exercise | A | 11.34 | 964,665 | 10,939,301 | 964,665 | |
| Dec 21 2012 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Payment of Exercise | F | 11.34 | 14,728 | 167,016 | 2,407,829 | 2.4 M to 2.4 M (-0.61 %) |
| Dec 21 2012 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Grant | A | 11.34 | 163,139 | 1,849,996 | 2,422,557 | 2.3 M to 2.4 M (+7.22 %) |
| Dec 21 2012 | SPPI | SPECTRUM PHARMACEU ... | Arora Krishan K | Director | Option Exercise | A | 11.34 | 20,000 | 226,800 | 20,000 | |
| Dec 21 2012 | SPPI | SPECTRUM PHARMACEU ... | Arora Krishan K | Director | Grant | A | 11.34 | 10,000 | 113,400 | 15,000 | 5 K to 15 K (+200.00 %) |
| Dec 21 2012 | SPPI | SPECTRUM PHARMACEU ... | Gagnon Gilles | Director | Option Exercise | A | 11.34 | 20,000 | 226,800 | 20,000 | |
| Dec 21 2012 | SPPI | SPECTRUM PHARMACEU ... | Gagnon Gilles | Director | Grant | A | 11.34 | 10,000 | 113,400 | 35,000 | 25 K to 35 K (+40.00 %) |
| Dec 21 2012 | SPPI | SPECTRUM PHARMACEU ... | GUETH ANTON | Director | Option Exercise | A | 11.34 | 20,000 | 226,800 | 20,000 | |
| Dec 21 2012 | SPPI | SPECTRUM PHARMACEU ... | GUETH ANTON | Director | Grant | A | 11.34 | 10,000 | 113,400 | 11,000 | 1,000 to 11 K (+1,000.00 %) |
| Dec 04 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Option Exercise | M | 4.26 | 5,000 | 21,300 | 0 | |
| Dec 04 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Sell | S | 11.65 | 5,000 | 58,265 | 2,250 | 7.3 K to 2.3 K (-68.97 %) |
| Dec 04 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Buy | M | 4.26 | 5,000 | 21,300 | 7,250 | 2.3 K to 7.3 K (+222.22 %) |
| Dec 21 2012 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Option Exercise | A | 11.34 | 20,000 | 226,800 | 20,000 | |
| Dec 21 2012 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Grant | A | 11.34 | 10,000 | 113,400 | 10,000 | 0 to 10 K |
| Dec 21 2012 | SPPI | SPECTRUM PHARMACEU ... | LENAZ LUIGI MD | Director | Option Exercise | A | 11.34 | 20,000 | 226,800 | 20,000 | |
| Dec 21 2012 | SPPI | SPECTRUM PHARMACEU ... | LENAZ LUIGI MD | Director | Payment of Exercise | F | 11.34 | 2,800 | 31,752 | 29,077 | 31.9 K to 29.1 K (-8.78 %) |
| Dec 21 2012 | SPPI | SPECTRUM PHARMACEU ... | LENAZ LUIGI MD | Director | Grant | A | 11.34 | 10,000 | 113,400 | 31,877 | 21.9 K to 31.9 K (+45.71 %) |
| Dec 03 2012 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Payment of Exercise | F | 11.20 | 54,675 | 612,360 | 2,262,241 | 2.3 M to 2.3 M (-2.36 %) |
| Nov 13 2012 | SPPI | SPECTRUM PHARMACEU ... | Keller Joseph Kenneth | EVP & Chief Operati ... | Buy | P | 10.95 | 10,000 | 109,469 | 138,000 | 128 K to 138 K (+7.81 %) |
| Nov 02 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Option Exercise | M | 4.26 | 1,700 | 7,242 | 13,300 | |
| Nov 02 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Option Exercise | M | 2.55 | 3,300 | 8,415 | 0 | |
| Nov 02 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Sell | S | 11.07 | 1,700 | 18,817 | 2,250 | 4 K to 2.3 K (-43.04 %) |
| Nov 02 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Buy | M | 4.26 | 1,700 | 7,242 | 3,950 | 2.3 K to 4 K (+75.56 %) |
| Nov 02 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Sell | S | 11.10 | 3,300 | 36,622 | 2,250 | 5.6 K to 2.3 K (-59.46 %) |
| Nov 02 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Buy | M | 2.55 | 3,300 | 8,415 | 5,550 | 2.3 K to 5.6 K (+146.67 %) |
| Oct 11 2012 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Sell | S | 12.50 | 11,350 | 141,875 | 2,316,916 | 2.3 M to 2.3 M (-0.49 %) |
| Oct 03 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Option Exercise | M | 6.65 | 5,000 | 33,250 | 0 | |
| Oct 03 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Sell | S | 11.80 | 5,000 | 59,009 | 2,250 | 7.3 K to 2.3 K (-68.97 %) |
| Oct 03 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Buy | M | 6.65 | 5,000 | 33,250 | 7,250 | 2.3 K to 7.3 K (+222.22 %) |
| Oct 02 2012 | SPPI | SPECTRUM PHARMACEU ... | Scott Brett L | Acting Chief Financ ... | Sell | S | 12.00 | 6,000 | 72,000 | 45,661 | 51.7 K to 45.7 K (-11.61 %) |
| Sep 20 2012 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Sell | S | 12.50 | 4,800 | 60,000 | 2,328,134 | 2.3 M to 2.3 M (-0.21 %) |
| Sep 20 2012 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Sell | S | 12.74 | 33,000 | 420,394 | 2,332,934 | 2.4 M to 2.3 M (-1.39 %) |
| Sep 20 2012 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Sell | S | 13.02 | 33,000 | 429,591 | 2,365,934 | 2.4 M to 2.4 M (-1.38 %) |
| Sep 11 2012 | SPPI | SPECTRUM PHARMACEU ... | Keller Joseph Kenneth | EVP & Chief Operati ... | Option Exercise | A | 12.01 | 300,000 | 3,603,000 | 300,000 | |
| Sep 11 2012 | SPPI | SPECTRUM PHARMACEU ... | Keller Joseph Kenneth | EVP & Chief Operati ... | Grant | A | 0.00 | 100,000 | 0 | 128,000 | 28 K to 128 K (+357.14 %) |
| Sep 11 2012 | SPPI | SPECTRUM PHARMACEU ... | Keller Joseph Kenneth | EVP & Chief Operati ... | Grant | A | 0.00 | 20,000 | 0 | 28,000 | 8 K to 28 K (+250.00 %) |
| Sep 10 2012 | SPPI | SPECTRUM PHARMACEU ... | Scott Brett L | Acting Chief Financ ... | Option Exercise | A | 12.01 | 25,000 | 300,250 | 25,000 | |
| Sep 10 2012 | SPPI | SPECTRUM PHARMACEU ... | Shields James | Chief Commercial Of ... | Option Exercise | A | 12.01 | 25,000 | 300,250 | 25,000 | |
| Sep 07 2012 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Sell | S | 12.63 | 34,000 | 429,335 | 2,398,934 | 2.4 M to 2.4 M (-1.40 %) |
| Sep 07 2012 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Sell | S | 12.53 | 33,000 | 413,573 | 2,432,934 | 2.5 M to 2.4 M (-1.34 %) |
| Sep 06 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Option Exercise | M | 6.65 | 5,000 | 33,250 | 5,000 | |
| Sep 06 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Sell | S | 12.01 | 5,000 | 60,040 | 2,250 | 7.3 K to 2.3 K (-68.97 %) |
| Sep 06 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Buy | M | 6.65 | 5,000 | 33,250 | 7,250 | 2.3 K to 7.3 K (+222.22 %) |
| Sep 06 2012 | SPPI | SPECTRUM PHARMACEU ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 1.82 | 130,854,840 | 238,155,809 | 1,000 | -130,853,840 to 1,000 (-100.00 %) |
| Aug 20 2012 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Sell | S | 12.58 | 5,750 | 72,335 | 0 | 5.8 K to 0 (-100.00 %) |
| Aug 16 2012 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Sell | S | 12.61 | 84,000 | 1,058,887 | 2,465,934 | 2.5 M to 2.5 M (-3.29 %) |
| Aug 16 2012 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Sell | S | 12.54 | 83,000 | 1,040,447 | 2,549,934 | 2.6 M to 2.5 M (-3.15 %) |
| Aug 16 2012 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Sell | S | 12.53 | 41,500 | 519,995 | 2,632,934 | 2.7 M to 2.6 M (-1.55 %) |
| Aug 10 2012 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Option Exercise | M | 1.06 | 75,000 | 79,163 | 0 | |
| Aug 10 2012 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Buy | M | 1.06 | 75,000 | 79,163 | 2,674,434 | 2.6 M to 2.7 M (+2.89 %) |
| Jul 16 2012 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Sell | S | 16.61 | 3,000 | 49,830 | 5,750 | 8.8 K to 5.8 K (-34.29 %) |
| Jul 16 2012 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Sell | S | 16.27 | 2,000 | 32,540 | 8,750 | 10.8 K to 8.8 K (-18.60 %) |
| Jul 12 2012 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Option Exercise | M | 1.47 | 68,027 | 100,000 | 250,426 | |
| Jul 12 2012 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Buy | M | 1.47 | 68,027 | 100,000 | 2,605,870 | 2.5 M to 2.6 M (+2.68 %) |
| Apr 03 2012 | SPPI | SPECTRUM PHARMACEU ... | Gagnon Gilles | Director | Option Exercise | A | 12.71 | 7,500 | 95,325 | 7,500 | |
| Apr 02 2012 | SPPI | SPECTRUM PHARMACEU ... | GUETH ANTON | Director | Option Exercise | A | 12.71 | 7,500 | 95,325 | 7,500 | |
| Mar 06 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Option Exercise | M | 2.55 | 2,500 | 6,375 | 3,300 | |
| Mar 06 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Option Exercise | M | 2.55 | 3,200 | 8,160 | 5,800 | |
| Mar 06 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Sell | S | 12.70 | 2,500 | 31,750 | 2,250 | 4.8 K to 2.3 K (-52.63 %) |
| Mar 06 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Buy | M | 2.55 | 2,500 | 6,375 | 4,750 | 2.3 K to 4.8 K (+111.11 %) |
| Mar 06 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Sell | S | 12.83 | 3,200 | 41,056 | 2,250 | 5.5 K to 2.3 K (-58.72 %) |
| Mar 06 2012 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Buy | M | 2.55 | 3,200 | 8,160 | 5,450 | 2.3 K to 5.5 K (+142.22 %) |
| Jan 17 2012 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Payment of Exercise | F | 14.63 | 16,848 | 246,486 | 2,490,517 | 2.5 M to 2.5 M (-0.67 %) |
| Dec 30 2011 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Option Exercise | M | 1.47 | 31,547 | 46,374 | 318,453 | |
| Dec 30 2011 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Option Exercise | M | 1.43 | 37,500 | 53,625 | 112,500 | |
| Dec 30 2011 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Option Exercise | M | 5.53 | 17,985 | 99,457 | 332,015 | |
| Dec 30 2011 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Option Exercise | M | 4.23 | 70,752 | 299,281 | 129,248 | |
| Dec 30 2011 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Option Exercise | M | 1.99 | 18,552 | 36,918 | 206,448 | |
| Dec 30 2011 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Option Exercise | M | 4.90 | 17,500 | 85,750 | 197,500 | |
| Dec 30 2011 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Option Exercise | M | 4.75 | 12,000 | 57,000 | 0 | |
| Dec 30 2011 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Buy | M | 1.47 | 31,547 | 46,374 | 2,507,365 | 2.5 M to 2.5 M (+1.27 %) |
| Dec 30 2011 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Buy | M | 1.43 | 37,500 | 53,625 | 2,475,818 | 2.4 M to 2.5 M (+1.54 %) |
| Dec 30 2011 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Buy | M | 5.53 | 17,985 | 99,457 | 2,438,318 | 2.4 M to 2.4 M (+0.74 %) |
| Dec 30 2011 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Buy | M | 4.23 | 70,752 | 299,281 | 2,420,333 | 2.3 M to 2.4 M (+3.01 %) |
| Dec 30 2011 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Buy | M | 1.99 | 18,552 | 36,918 | 2,349,581 | 2.3 M to 2.3 M (+0.80 %) |
| Dec 30 2011 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Buy | M | 4.90 | 17,500 | 85,750 | 2,331,029 | 2.3 M to 2.3 M (+0.76 %) |
| Dec 30 2011 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Buy | M | 4.75 | 12,000 | 57,000 | 2,313,529 | 2.3 M to 2.3 M (+0.52 %) |
| Dec 23 2011 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Payment of Exercise | F | 14.77 | 189,540 | 2,799,506 | 2,351,529 | 2.5 M to 2.4 M (-7.46 %) |
| Dec 23 2011 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Grant | A | 14.77 | 520,000 | 7,680,400 | 2,541,069 | 2 M to 2.5 M (+25.73 %) |
| Dec 23 2011 | SPPI | SPECTRUM PHARMACEU ... | Scott Brett L | Acting Chief Financ ... | Payment of Exercise | F | 14.77 | 40,179 | 593,444 | 50,321 | 90.5 K to 50.3 K (-44.40 %) |
| Dec 23 2011 | SPPI | SPECTRUM PHARMACEU ... | Scott Brett L | Acting Chief Financ ... | Grant | A | 14.77 | 86,500 | 1,277,605 | 90,500 | 4 K to 90.5 K (+2,162.50 %) |
| Dec 23 2011 | SPPI | SPECTRUM PHARMACEU ... | Shields James | Chief Commercial Of ... | Payment of Exercise | F | 14.77 | 36,719 | 542,340 | 87,806 | 124.5 K to 87.8 K (-29.49 %) |
| Dec 23 2011 | SPPI | SPECTRUM PHARMACEU ... | Shields James | Chief Commercial Of ... | Grant | A | 14.77 | 86,500 | 1,277,605 | 124,525 | 38 K to 124.5 K (+227.48 %) |
| Dec 01 2011 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Grant | A | 0.00 | 600,000 | 0 | 2,021,069 | 1.4 M to 2 M (+42.22 %) |
| Dec 01 2011 | SPPI | SPECTRUM PHARMACEU ... | Shields James | Chief Commercial Of ... | Grant | A | 0.00 | 10,000 | 0 | 38,025 | 28 K to 38 K (+35.68 %) |
| Jul 01 2011 | SPPI | SPECTRUM PHARMACEU ... | Shields James | Chief Commercial Of ... | Option Exercise | A | 9.11 | 1,000 | 9,110 | 1,000 | |
| Jun 14 2011 | SPPI | SPECTRUM PHARMACEU ... | LENAZ LUIGI MD | Director | Option Exercise | A | 8.27 | 50,000 | 413,500 | 50,000 | |
| Jun 14 2011 | SPPI | SPECTRUM PHARMACEU ... | Scott Brett L | Acting Chief Financ ... | Option Exercise | A | 8.27 | 50,000 | 413,500 | 50,000 | |
| Jun 14 2011 | SPPI | SPECTRUM PHARMACEU ... | MEHTA DILIP J MD PHD | Director | Option Exercise | A | 8.27 | 50,000 | 413,500 | 50,000 | |
| Jun 14 2011 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Option Exercise | A | 8.27 | 50,000 | 413,500 | 50,000 | |
| Jun 14 2011 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Option Exercise | A | 8.27 | 50,000 | 413,500 | 50,000 | |
| Jun 14 2011 | SPPI | SPECTRUM PHARMACEU ... | Shields James | Chief Commercial Of ... | Option Exercise | A | 8.27 | 100,000 | 827,000 | 100,000 | |
| Jun 14 2011 | SPPI | SPECTRUM PHARMACEU ... | Arora Krishan K | Director | Option Exercise | A | 8.27 | 50,000 | 413,500 | 50,000 | |
| Jun 14 2011 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Option Exercise | A | 8.27 | 500,000 | 4,135,000 | 500,000 | |
| May 13 2011 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Option Exercise | M | 2.55 | 3,000 | 7,650 | 9,000 | |
| May 13 2011 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Sell | S | 7.59 | 3,000 | 22,770 | 2,250 | 5.3 K to 2.3 K (-57.14 %) |
| May 13 2011 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Buy | M | 2.55 | 3,000 | 7,650 | 5,250 | 2.3 K to 5.3 K (+133.33 %) |
| May 05 2011 | SPPI | SPECTRUM PHARMACEU ... | Shields James | Chief Commercial Of ... | Option Exercise | A | 8.79 | 25,000 | 219,750 | 69,483 | |
| Jan 21 2011 | SPPI | SPECTRUM PHARMACEU ... | Scott Brett L | Acting Chief Financ ... | Buy | P | 6.05 | 4,000 | 24,180 | 4,000 | 0 to 4 K |
| Jan 04 2011 | SPPI | SPECTRUM PHARMACEU ... | Shields James | Chief Commercial Of ... | Option Exercise | A | 6.87 | 50,000 | 343,500 | 50,000 | |
| Jan 04 2011 | SPPI | SPECTRUM PHARMACEU ... | Shields James | Chief Commercial Of ... | Grant | A | 0.00 | 20,000 | 0 | 21,500 | 1.5 K to 21.5 K (+1,333.33 %) |
| Jan 03 2011 | SPPI | SPECTRUM PHARMACEU ... | KUMARIA SHYAM K | Sr. Vice President ... | Option Exercise | A | 6.87 | 50,000 | 343,500 | 50,000 | |
| Jan 03 2011 | SPPI | SPECTRUM PHARMACEU ... | KUMARIA SHYAM K | Sr. Vice President ... | Grant | A | 0.00 | 20,000 | 0 | 218,471 | 198.5 K to 218.5 K (+10.08 %) |
| Jan 03 2011 | SPPI | SPECTRUM PHARMACEU ... | TIDMARSH GEORGE F | CSO and Head of R&D ... | Option Exercise | A | 6.87 | 50,000 | 343,500 | 50,000 | |
| Jan 03 2011 | SPPI | SPECTRUM PHARMACEU ... | TIDMARSH GEORGE F | CSO and Head of R&D ... | Grant | A | 0.00 | 20,000 | 0 | 40,000 | 20 K to 40 K (+100.00 %) |
| Jan 03 2011 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Option Exercise | A | 6.87 | 1,000,000 | 6,870,000 | 1,000,000 | |
| Jan 03 2011 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Grant | A | 0.00 | 250,000 | 0 | 1,423,486 | 1.2 M to 1.4 M (+21.30 %) |
| Nov 17 2010 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Option Exercise | M | 2.55 | 5,000 | 12,750 | 12,000 | |
| Nov 17 2010 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Sell | S | 4.46 | 5,000 | 22,310 | 2,250 | 7.3 K to 2.3 K (-68.97 %) |
| Nov 17 2010 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Buy | M | 2.55 | 5,000 | 12,750 | 7,250 | 2.3 K to 7.3 K (+222.22 %) |
| Oct 12 2010 | SPPI | SPECTRUM PHARMACEU ... | Scott Brett L | Acting Chief Financ ... | Option Exercise | A | 4.28 | 100,000 | 428,000 | 100,000 | |
| Sep 10 2010 | SPPI | SPECTRUM PHARMACEU ... | MEHTA DILIP J MD PHD | Director | Option Exercise | G | 6.66 | 20,000 | 133,200 | 0 | |
| Sep 10 2010 | SPPI | SPECTRUM PHARMACEU ... | MEHTA DILIP J MD PHD | Director | Option Exercise | G | 6.56 | 20,000 | 131,200 | 0 | |
| Sep 10 2010 | SPPI | SPECTRUM PHARMACEU ... | MEHTA DILIP J MD PHD | Director | Option Exercise | G | 6.09 | 10,000 | 60,900 | 0 | |
| Sep 10 2010 | SPPI | SPECTRUM PHARMACEU ... | MEHTA DILIP J MD PHD | Director | Option Exercise | G | 6.05 | 20,000 | 121,000 | 0 | |
| Sep 10 2010 | SPPI | SPECTRUM PHARMACEU ... | MEHTA DILIP J MD PHD | Director | Option Exercise | G | 4.90 | 5,000 | 24,500 | 0 | |
| Sep 10 2010 | SPPI | SPECTRUM PHARMACEU ... | MEHTA DILIP J MD PHD | Director | Option Exercise | G | 4.26 | 15,000 | 63,900 | 0 | |
| Aug 16 2010 | SPPI | SPECTRUM PHARMACEU ... | TIDMARSH GEORGE F | CSO AND HEAD OF R&D ... | Buy | P | 4.03 | 5,000 | 20,150 | 20,000 | 15 K to 20 K (+33.33 %) |
| Jul 06 2010 | SPPI | SPECTRUM PHARMACEU ... | MEHTA DILIP J MD PHD | Director | Buy | P | 3.74 | 10,000 | 37,367 | 32,000 | 22 K to 32 K (+45.45 %) |
| Jul 19 2010 | SPPI | SPECTRUM PHARMACEU ... | TIDMARSH GEORGE F | CSO AND HEAD OF R&D ... | Option Exercise | A | 4.02 | 200,000 | 804,000 | 200,000 | |
| Jul 19 2010 | SPPI | SPECTRUM PHARMACEU ... | TIDMARSH GEORGE F | CSO AND HEAD OF R&D ... | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Jul 01 2010 | SPPI | SPECTRUM PHARMACEU ... | KUMARIA SHYAM K | Sr. Vice President ... | Option Exercise | A | 3.92 | 100,000 | 392,000 | 100,000 | |
| Jul 01 2010 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Option Exercise | A | 3.92 | 500,000 | 1,960,000 | 500,000 | |
| Jul 01 2010 | SPPI | SPECTRUM PHARMACEU ... | MEHTA DILIP J MD PHD | Director | Option Exercise | A | 3.92 | 30,000 | 117,600 | 30,000 | |
| Jul 01 2010 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Option Exercise | A | 3.92 | 30,000 | 117,600 | 30,000 | |
| Jul 01 2010 | SPPI | SPECTRUM PHARMACEU ... | LENAZ LUIGI MD | Director | Option Exercise | A | 3.92 | 30,000 | 117,600 | 30,000 | |
| Jul 01 2010 | SPPI | SPECTRUM PHARMACEU ... | Arora Krishan K | Director | Option Exercise | A | 3.92 | 30,000 | 117,600 | 30,000 | |
| Jul 01 2010 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Option Exercise | A | 3.92 | 30,000 | 117,600 | 30,000 | |
| Jun 24 2010 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Buy | P | 3.84 | 10,000 | 38,367 | 1,173,486 | 1.2 M to 1.2 M (+0.86 %) |
| Jun 07 2010 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman, CEO & Pre ... | Buy | P | 3.96 | 10,000 | 39,603 | 1,163,486 | 1.2 M to 1.2 M (+0.87 %) |
| Apr 21 2010 | SPPI | SPECTRUM PHARMACEU ... | VIDA JULIUS A | Director | Option Exercise | A | 5.05 | 30,000 | 151,500 | 30,000 | |
| Apr 21 2010 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Option Exercise | A | 5.05 | 30,000 | 151,500 | 30,000 | |
| Apr 21 2010 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Option Exercise | A | 5.05 | 30,000 | 151,500 | 30,000 | |
| Apr 21 2010 | SPPI | SPECTRUM PHARMACEU ... | Fulmer Richard | Director | Option Exercise | A | 5.05 | 30,000 | 151,500 | 30,000 |